About Vedanta Biosciences
Vedanta Biosciences is a private company based in Cambridge, Massachusetts. It has reported $240,301,373 raised in four offerings on Form D since February 2019.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Mar 1, 2023 | May 2, 2023amended Aug 5, 2024 | $118,500,000fully sold | 25 | $4.7M | Debt, OptionsRule 506(b) | Form D/A ↗1 earlier filing |
| Jul 16, 2021 | Aug 13, 2021 | $68,406,915of $74.9M target | 18 | $3.8M | EquityRule 506(b) | Form D ↗ |
| Sep 11, 2019 | Sep 19, 2019 | $7,999,939of $16.5M target | 4 | $1.9M | EquityRule 506(b) | Form D ↗ |
| Dec 21, 2018 | Feb 5, 2019amended May 8, 2019 | $45,394,519of $49.9M target | 13 | $3.4M | EquityRule 506(b) | Form D/A ↗2 earlier filings |
| Total, four offerings | $240,301,373 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Vedanta Biosciences's Form D filed Aug 5, 2024.
JL
John LaMattina
Director
CS
Charles Sherwood
Director
SD
Susan Dillon
Director
MH
Martin Heidecker
Director
NT
Neil Tiwari
Director
CL
Curt LaBelle
Director
DC
Daniel Couto
Executive officer
BO
Bernat Olle
Executive officer and director
MM
Mark Mullikin
Treasurer
BS
Bennett Shapiro
Director
TI
Troy Ignelzi
Director
JS
Jeffrey Silber
Executive officer
Earlier filings also listed Christopher Viehbacher (director, last listed Aug 2021) and Bharatt Chowrira (director, last listed Aug 2021).